Trupanion, Inc. (Nasdaq: TRUP), a leader in medical insurance for cats and dogs, announced today that Fawwad Qureshi, Chief Financial Officer, will present at the 46th Annual Raymond James ...

Trupanion reported mixed earnings with revenue exceeding expectations despite a shortfall in earnings per share (EPS).

(Nasdaq: TRUP), a leading provider of medical insurance for cats and dogs, today announced financial results for the fourth ...

Research analysts at William Blair cut their Q1 2025 EPS estimates for Trupanion in a note issued to investors on Thursday, ...

Stifel Nicolaus analyst Jonathan Block maintained a Hold rating on Trupanion (TRUP – Research Report) on February 23 and set a price target of ...

Trupanion (NASDAQ:TRUP – Free Report) had its target price trimmed by Piper Sandler from $57.00 to $52.00 in a research ...

Trupanion, Inc.’s TRUP share price has dipped by 25.49%, which has investors questioning if this is right time to buy.

Trupanion showed a significant turnaround with a net income of $1.7 million compared to a loss last year. Founded on a subscription-based business model, Trupanion generates predictable revenue by ...

Trupanion's Q4 2024 earnings show record margins, 20% subscription revenue growth, and innovative strategies for long-term objectives.

Full Year 2024 Results Key Financial Results Revenue: US$1.29b (up 16% from FY 2023).

Trupanion, Inc. (Nasdaq: TRUP), a leading provider of medical insurance for cats and dogs, today announced financial results ...